Microbix Biosystems (TSX:MBX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.62) by 98.39 percent. The company reported quarterly sales of $3.378 million which beat the analyst consensus estimate of $3.374 million by 0.12 percent. This is a 36.56 percent decrease over sales of $5.325 million the same period last year.